[breadcrumb_custom]

Zai Lab Limited ADR Inc. (ZLAB) Price Performance: The Role of Supply and Demand

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -28.06%. However, over the last six months, the performance has been stronger by -18.73%. The price of ZLAB decreased -26.64% over the last 30 days. And in the last five days, it has fallen by -8.85%.

Zai Lab Limited ADR’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $41.79 on 03/03/23 and a low of $19.88 for the same time frame on 02/07/24.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

52-week price history of ZLAB Stock

Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Zai Lab Limited ADR’s current trading price is -52.96% away from its 52-week high, while its distance from the 52-week low is -1.11%. The stock’s price range during this time has been between $19.88 and $41.79. The trading volume for the Healthcare sector company’s shares reached about 1.68 million for the day, which was higher than the average daily volume of 0.55 million over the last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Zai Lab Limited ADR (ZLAB) has experienced a quarterly decline of -29.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.94B and boasts a workforce of 2036 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 25.56, with a change in price of -5.92. Similarly, Zai Lab Limited ADR recorded 505,657 in trading volume during the last 100 days, posting a change of -23.14%.

ZLAB’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ZLAB stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.

ZLAB Stock Stochastic Average

Today’s raw stochastic average for Zai Lab Limited ADR over the last 50 days is 2.78%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 4.31%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 18.89% and 26.74%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts